Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3312825 | Journal of Crohn's and Colitis | 2011 | 6 Pages |
Abstract
Our results show a lasting benefit of infliximab rescue therapy in 61% of patients with acute, steroid-refractory ulcerative colitis, a low incidence of late colectomies, and low frequency of steroid use in patients who avoided colectomy. High levels of C-reactive protein on admittance and at the first infliximab infusion were associated with colectomy. Our study adds to the growing experience of infliximab treatment of patients with acute, steroid-refractory ulcerative colitis.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Christian Mortensen, Sarah Caspersen, Niels Lyhne Christensen, Lise Svenningsen, Niels Thorsgaard, Lisbet Ambrosius Christensen, Flemming Bendtsen,